Prostate Cancer With Metastatic Lytic Bone Lesions: Positive Bone Scan Post Docetaxel Chemotherapy in the Setting of Clinically Successful Treatment

Current treatment of metastatic bone prostate cancer with Docetaxel chemotherapy per CHAARTED trial is standard of care. Timing of CT and bone scintigraphy for evaluation of successful treatment of lytic lesions is not available in the literature. We present a case of a 70 year old male with PSA of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bird, Victoria Yvonne, Domino, Paula M., Sutkowski, Raymond, Stillings, Stephanie A., Trejo-Lopez, Jorge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855904/
https://www.ncbi.nlm.nih.gov/pubmed/27169018
http://dx.doi.org/10.1016/j.eucr.2015.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855904/
https://www.ncbi.nlm.nih.gov/pubmed/27169018
http://dx.doi.org/10.1016/j.eucr.2015.12.008

Ejemplares similares